RISPERIDONE DEPOT vs RISPERIDONE
Relapse · patients with schizophrenia
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
Findings
What do systematic reviews say?
8 questions · 8 findings · 1 reviews
No studies found 1 · 12.5%GRADE not reported 5 · 62.5%Very low 1 · 12.5%Low 1 · 12.5%Moderate 0 · 0%High 0 · 0%
RISPERIDONE DEPOT vs QUETIAPINE
Relapse · patients with schizophrenia
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
RISPERIDONE DEPOT vs OLANZAPINE
Relapse · patients with schizophrenia
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
RISPERIDONE DEPOT vs ATYPICAL DEPOT ANTIPSYCHOTICS (PALIPERIDONE PALMITATE)
Relapse · patients with schizophrenia
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
RISPERIDONE DEPOT vs TYPICAL DEPOT ANTIPSYCHOTICS
Relapse · patients with schizophrenia
1 finding from 1 review
- no estimate extracted0 studies · 0 participantsGRADE not reported
RISPERIDONE DEPOT vs placebo
Global state: Relapse ‐ long term ‐ not measured · patients with schizophrenia
The review found no eligible studies for this question.
1 finding from 1 review
- no estimate extractedStudies not reportedNo studies found
RISPERIDONE DEPOT vs GENERAL ORAL ANTIPSYCHOTICS
Relapse · patients with schizophrenia
It is very uncertain whether RISPERIDONE DEPOT changes global state: Relapse (any reason) ‐ long term Number of… compared with GENERAL ORAL ANTIPSYCHOTICS (very low certainty).
1 finding from 1 review
- RR 2.13 [0.84, 5.43]1 study · 63 participantsVery low
RISPERIDONE DEPOT vs ARIPIPRAZOLE
Relapse · patients with schizophrenia
RISPERIDONE DEPOT showed no clear difference in global state: Relapse (any reason) ‐ long term Assessed by 5 blinded… compared with ORAL ARIPIPRAZOLE (low certainty).
1 finding from 1 review
- RR 1.05 [0.83, 1.33]1 study · 349 participantsLow